ImmuniWeb® Continuous Penetration Testing is a commercial penetration testing solution by ImmuniWeb. PT Dephaze is a commercial penetration testing solution by Positive Technologies. Features, integrations, deployment and the company behind each one, side by side.
Continuous pentesting service monitoring web apps & APIs for code changes
Agentless automated pentest platform for continuous infrastructure security testing.
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
ImmuniWeb® Continuous Penetration Testing fits if you want a cloud product and you are a small business.
PT Dephaze fits if you need to run it on your own servers.
Common questions when comparing ImmuniWeb® Continuous Penetration Testing vs PT Dephaze for penetration testing.
ImmuniWeb® Continuous Penetration Testing: Continuous pentesting service monitoring web apps & APIs for code changes, built by ImmuniWeb.
PT Dephaze: Agentless automated pentest platform for continuous infrastructure security testing, built by Positive Technologies.
The table above shows where their features, integrations, deployment and company size fit differ.
ImmuniWeb® Continuous Penetration Testing is made by ImmuniWeb. PT Dephaze is made by Positive Technologies. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. ImmuniWeb® Continuous Penetration Testing and PT Dephaze are both Penetration Testing products, and both cover Continuous Testing, Red Team. Use the table above to see where features, deployment and company size fit differ.
